RLEFX
Price
$35.60
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
246.53B
TBLRX
Price
$11.96
Change
-$0.10 (-0.83%)
Updated
Jun 13 closing price
Net Assets
68.43M
Interact to see
Advertisement

RLEFX vs TBLRX

Header iconRLEFX vs TBLRX Comparison
Open Charts RLEFX vs TBLRXBanner chart's image
American Funds American Balanced R5E
Price$35.60
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets246.53B
Transamerica Balanced II R
Price$11.96
Change-$0.10 (-0.83%)
VolumeN/A
Net Assets68.43M
RLEFX vs TBLRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLEFX vs. TBLRX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLEFX is a Buy and TBLRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 247B vs. TBLRX (68.4M). RLEFX pays higher dividends than TBLRX: RLEFX (2.09) vs TBLRX (1.46). RLEFX was incepted earlier than TBLRX: RLEFX (10 years) vs TBLRX (31 years). TBLRX (1.11) is less costly to investors than RLEFX (0.39). RLEFX is a more actively managed with annual turnover of: 44.00 vs. TBLRX (38.00). TBLRX has a lower initial minimum investment than RLEFX: TBLRX (0) vs RLEFX (250). RLEFX annual gain was more profitable for investors over the last year : 5.49 vs. TBLRX (-5.11). RLEFX return over 5 years is better than : 39.46 vs. TBLRX (12.97).
RLEFXTBLRXRLEFX / TBLRX
Total Expense Ratio0.391.1035%
Annual Report Gross Expense Ratio0.391.1135%
Fund Existence10 years31 years-
Gain YTD4.5242.264200%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets247B68.4M361,111%
Annual Yield % from dividends2.091.46143%
Returns for 1 year5.49-5.11-108%
Returns for 3 years33.2815.76211%
Returns for 5 years39.4612.97304%
Returns for 10 yearsN/A31.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp
ARQQ23.78-2.94
-11.00%
Arqit Quantum Inc